Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Training to improve emotion regulation in people with Borderline Personality Disorder

Official title: Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients

Run by Icahn School of Medicine at Mount Sinai · NCT06772831 · Data updated 2026-11-12

This study is testing a new training program to help people with Borderline Personality Disorder learn better ways to manage their emotions.

More Borderline Personality Disorder trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment130 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT06772831 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are medically healthy adults aged 18 to 55 who have been diagnosed with Borderline Personality Disorder.

Probably not a fit

Patients with comorbid conditions such as Major Depressive Disorder or other specified personality disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on developing and testing a cognitive reappraisal training program aimed at individuals with Borderline Personality Disorder (BPD). The intervention involves teaching participants to use cognitive strategies to manage their emotional responses more effectively. By examining the neural and behavioral impacts of this training, the researchers aim to establish its efficacy in improving clinical outcomes for BPD patients. The study seeks to address the significant treatment gap for BPD, where current therapies have limited effectiveness.

Why it matters

Potential benefit: If successful, this training could significantly enhance emotional regulation and reduce the severity of symptoms in patients with BPD.

How similar studies have gone: Previous studies have shown promise in using cognitive reappraisal techniques for emotional regulation, suggesting potential success for this novel approach in treating BPD.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Medically healthy men and women with Borderline Personality Disorder who are mentally competent and give informed voluntary written consent.
* Participants will be between the ages of 18 and 55.
* Within these requirements, the inclusion and exclusion criteria do not reflect participation based on gender or racial/ethnic group. The targeted/planned enrollment is a reflection of previous recruitment of female and ethnic minorities in other studies conducted by the PI and their colleagues and includes representations of both genders and all minorities.
* Participants with comorbid avoidant personality disorder will be included.
* Participants who meet criteria for PTSD will be included as long as they are not actively experiencing symptoms.

Exclusion Criteria:

* Participants will not meet criteria for Schizotypal Personality Disorder.
* Participants currently meeting criteria for Major Depressive Disorder will be excluded.
* BPD participants will not meet DSM-5 criteria for present PTSD, bipolar I disorder, schizophrenia, schizoaffective disorder, substance use disorder within the past 6 months, organic mental syndromes, head trauma, schizotypal personality disorder, avoidant personality disorder, CNS neurological disease, or seizure disorder. Participants meeting criteria for a non-IV substance use disorder more than 6 months prior to enrollment will not be excluded. This study allows patients who are currently taking psychotropic medications or are in psychotherapy, so long as there has been no change in medication or psychotherapy over the preceding two months.
* Participants currently meeting criteria for major depressive disorder.
* Participants meeting criteria for substance use disorder within the last 6 months or of an IV-substance use disorder at any time.
* Participants may not have a pacemaker, surgical clips, any metallic implants, or shrapnel fragments that would contraindicate MRI scanning.
* Pregnant women.

Where it's running

  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.